Principal Investigators

    BEZARD Erwan

    Institution

    IMN Bordeaux

    Contact information of lead PI

    Country

    France

    Title of project or programme

    Modelling multi-factorial neurodegeneration in Parkinson’s disease: removing roadblocks towards the clinic

    Source of funding information

    ANR

    Total sum awarded (Euro)

    € 559,874

    Start date of award

    01/12/2012

    Total duration of award in years

    4.0

    The project/programme is most relevant to:

    Parkinson's disease|Neurodegenerative disease in general

    Keywords

    Research Abstract

    Modelling multi-factorial neurodegeneration in Parkinson’s disease:
    To date, NO mammalian model recapitulates the required age-dependent parkinsonian degeneration, the a-synuclein-inclusion pathology, the PD pathophysiology as well as the broad range of motor and non-motor parkinsonian symptoms. This absence prevents the development of neuroprotective and neurorestorative therapeutic strategies, constituting a fatal roadblock for both academia and industry in translating research into clinically-relevant discoveries.
    Modelling for derisking the translation
    Epidemiological and clinical evidences strongly suggest that PD results from a multifactorial etiology involving both genetic susceptibility factors and environmental exposures superimposing upon aging, the major risk factor for PD. Such multifactorial nature of the degenerative causes and processes has been overlooked so far, explaining the failure in truly replicating PD in mammals.
    Combining risk-factors
    We here propose four categories of mechanisms that we will combine into an integrated framework: (i) the role of aging, (ii) the role of the lysosomal dysfunction(s), (iii) the role of a-synuclein acting in a potential prion-like manner and, of paramount importance, (iv) the greater susceptibility of primate dopamine neurons versus rodent dopamine neurons for PD degeneration.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: France
Diseases: Neurodegenerative disease in general, Parkinson's disease & PD-related disorders
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF